A dietary supplement developed at the Baker Heart and Diabetes Institute has been found to stop the progression of heart ...
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
Bears owner Virginia McCaskey and Chairman of the Board Michael McCaskey react as they are presented with the George S. Halas ...
The researcher, a global liver damage expert, sounds the alarm over our limited awareness of the connection between drug ...
Cytokinetics (CYTK) was initiated by Citi analysts with a Buy rating, citing potential FDA approval for its lead asset ...
14h
The Atlantan on MSNMitzi Solomon Makes an Honorable Journey to Find a CureMitzi Solomon's Honorable Journey to Find a Cure Marc Bouwer dress, marcbouwer.com; Solomon Brothers Jewelers jewelry, ...
JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...
Hypertrophic cardiomyopathy is characterized by a thickening of the muscles in the heart and can disrupt the heart’s ...
Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...
The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...
Jared Butler gives his reaction to joining the Philadelphia 76ers and discusses his excitement to finally be joining Philadelphia.
BridgeBio could be an acquisition target, but current financial challenges and competition suggest a "Hold" rating until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results